In addition, in adults with extensive and partially cross-reactive pre-existing influenza immunity LAIV has been shown to boost secretory IgA responses to HA and non-HA antigenic targets expressed by circulating influenza strains (214). The gene discussed is CD79A; the disease is influenza.